Tag Archives: remdesivir

FDA approves Gilead’s remdesivir as coronavirus treatment

The Food and Drug Administration on Thursday approved Gilead Sciences‘ antiviral drug remdesivir as a treatment for the coronavirus. In May, the FDA granted the drug an emergency use authorization, allowing hospitals and doctors to use the drug on patients hospitalized with the disease even though the drug has not been formally approved by the… Read More »

Remdesivir, tested at Stanford Medicine, becomes first FDA-authorized COVID-19 treatment – Stanford Medical Center Report

Email Tweet Remdesivir, tested at Stanford Medicine, becomes first FDA-authorized COVID-19 treatment Stanford Medicine researchers who participated in two separate clinical trials are encouraged by data indicating that remdesivir can treat COVID-19. May 3 2020 Neera Ahuja Results from two eagerly awaited clinical trials of the experimental anti-viral drug remdesivir showed it is effective against… Read More »

U.S. emergency approval broadens use of Gilead’s COVID-19 drug remdesivir

WASHINGTON (Reuters) – Gilead Science Inc’s (GILD.O) antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States. During a meeting in the Oval Office of the White House with President… Read More »